Related Experiment Video
Updated: Jun 16, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Androgens and male aging: Current evidence of safety and efficacy
1Department of Endocrinology, VU University Medical Center, Amsterdam, the Netherlands. louisjgooren@gmail.com
Abstract:
Many signs of aging, such as sexual dysfunction, visceral obesity, impaired bone and muscle strength, bear a close resemblance to features of hypogonadism in younger men. The statistical decline of serum testosterone in aging men is solidly documented. It has been presumed that the above features of aging are related to the concurrent decline of androgens, and that correction of the lower-than-normal circulating levels of testosterone will lead to improvement of symptoms of aging. But in essence, the pivotal question whether the age-related decline of testosterone must be viewed as hypogonadism, in the best case reversed by testosterone treatment, has not been definitively resolved. Studies in elderly men with lower-than-normal testosterone report improvement of features of the metabolic syndrome, bone mineral density, of mood and of sexual functioning. But as yet there is no definitive proof of the beneficial effects of restoring testosterone levels to normal in elderly men on clinical parameters. Few of these studies meet as yet rigorous standards of scientific enquiry: double-blind, placebo-controlled design of the study. The above applies also to the assessment of safety of testosterone administration to elderly men. There is so far no convincing evidence that testosterone is a main factor in the development of prostate cancer in elderly men and guidelines for monitoring the development of prostate disease have been developed. It is of note that there are presently no long-term safety data with regard to the prostate. Polycythemia is another potential complication of testosterone treatment. It is dose dependent and can be managed with dose adjustment.
Insights
Aging men experience testosterone decline, but whether this is hypogonadism treatable with testosterone remains unclear. While some studies show benefits, rigorous proof and long-term safety data are still lacking.
Area of Science:
- Endocrinology
- Gerontology
- Men's Health
Background:
- Aging men often exhibit symptoms similar to hypogonadism, including sexual dysfunction, obesity, and reduced muscle/bone strength.
- A documented decline in serum testosterone levels occurs with aging in men.
- The causal link between age-related testosterone decline and aging symptoms, and the efficacy of testosterone replacement therapy (TRT), are not definitively established.
Purpose of the Study:
- To critically evaluate the evidence regarding the relationship between age-related testosterone decline and symptoms of aging in men.
- To assess the potential benefits and risks of testosterone administration in elderly men.
- To determine if testosterone decline in aging men constitutes hypogonadism treatable with TRT.
Main Methods:
- Review of existing studies investigating testosterone levels in aging men.
- Analysis of clinical trial data on testosterone replacement therapy in elderly men, focusing on symptom improvement.
- Evaluation of safety data, particularly concerning prostate health and polycythemia.
Main Results:
- Studies suggest potential improvements in metabolic syndrome, bone density, mood, and sexual function in elderly men with low testosterone treated with TRT.
- However, few studies meet rigorous scientific standards (e.g., double-blind, placebo-controlled).
- Current evidence does not definitively prove the clinical benefits of normalizing testosterone in elderly men, and long-term safety data, especially for prostate health, are limited. Polycythemia is a manageable risk.
Conclusions:
- The role of age-related testosterone decline as true hypogonadism treatable by testosterone is unresolved.
- While some benefits are suggested, robust evidence for the efficacy and long-term safety of TRT in aging men is lacking.
- Further high-quality research is needed to confirm benefits and establish safety profiles, particularly regarding prostate health.
Related Concept Videos
01:28Menopause
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
01:19The Effect of Aging on Tissues
01:26Testosterone: Functions and Regulation
01:15Drug Dosing: Geriatric Patients